Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Melanoma/Skin Cancer Health Center

Font Size

Experimental Melanoma Vaccine Shows Promise

'Personalized immunotherapy' may one day treat late-stage skin cancer

WebMD News from HealthDay

By Steven Reinberg

HealthDay Reporter

THURSDAY, July 11 (HealthDay News) -- Six of seven advanced melanoma patients had a positive response to an experimental vaccine, a finding that shows promise for personalized skin cancer treatment, researchers report.

The vaccine also slowed tumor progression in three of the patients, according to the investigators at the Washington University School of Medicine in St. Louis.

This cutting-edge approach -- considered by many the future of cancer treatment -- uses a patient's own cells to enhance an immune response to the attacking cancer cells and slow their growth, the study authors explained.

"This is personalized immunotherapy," said senior researcher Dr. Gerald Linette, an associate professor of medicine and neurosurgery.

Melanoma is the deadliest of skin cancers. Each year in the United States more than 76,000 cases of melanoma are diagnosed, and nearly 10,000 die from the disease, according to the U.S. National Cancer Institute.

The immune system plays a part in melanoma, Linette said, and the researchers wanted to see if a molecule called interleukin 12p70 could mount an immune response against the cancer.

"The results show that, in fact, interleukin 12p70 was very important in controlling the disease," he said. "It promoted a response where T cells of the immune system act directly against the melanoma."

Some patients make a lot of interleukin 12p70, and those are the patients who did well. But some patients make very little or no interleukin 12p70, and those are the patients who did worse, Linette said. For those patients, another way of enhancing the response will have to be tried, he said.

The study, published online July 11 in the Journal of Clinical Investigation, discusses use of the vaccine on seven patients with recently diagnosed stage IV cancer, meaning the cancer had spread to other areas of the body.

Dr. Michele Green, a dermatologist at Lenox Hill Hospital in New York City, said, "This is a great first step."

Techniques such as this will be standard some day, she believes. "We are at the infancy of this, but this is going to end up being the way we cure cancer," Green added.

Today on WebMD

Malignant melanoma
About 40-50 percent of those who live to be 65 may get it. Here’s how to spot early.
Woman checking out tan lines
There’s a dark side to that strive for beauty. See them here.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Lung cancer xray
See it in pictures, plus read the facts.
12 Ways to Protect Your Skin from Melanoma
precancerous lesions slideshow
Do You Know Your Melanoma ABCs
15 Cancer Symptoms Men Ignore
screening tests for men
Vitamin D
Is That Mole Skin Cancer
Brilliant sun rays